The epigenomics of polycystic ovarian syndrome: from pathogenesis to clinical manifestations

References

• Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol 2013;6:1–13.
   PubMed Web of Science ®Google Scholar
• Vink JM, Sadrzadeh S, Lambalk CB, Boomsma DI. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab 2006;91:2100–4.
   PubMed Web of Science ®Google Scholar
• Abbott DH, Barnett DK, Bruns CM, Dumesic DA. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update 2005;11:357–74.
   PubMed Web of Science ®Google Scholar
• Xita N, Tsatsoulis A. Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab 2006;91:1660–6.
   PubMed Web of Science ®Google Scholar
• Chen ZJ, Zhao H, He L, et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet 2011;43:55–9.
   PubMed Web of Science ®Google Scholar
• Handel AE, Ebers GC, Ramagopalan SV. Epigenetics: molecular mechanisms and implications for disease. Trends Mol Med 2010;16:7–16.
   PubMed Web of Science ®Google Scholar
• Holoch D, Moazed D. RNA-mediated epigenetic regulation of gene expression. Nat Rev Genet 2015;16:71–84.
   PubMed Web of Science ®Google Scholar
• Gluckman PD, Hanson MA, Buklijas T, et al. Epigenetic mechanisms that underpin metabolic and cardiovascular diseases. Nat Rev Endocrinol 2009;5:401–8.
   PubMed Web of Science ®Google Scholar
• Tan Q, Christiansen L, Thomassen M, et al. Twins for epigenetic studies of human aging and development. Ageing Res Rev 2013;12:182–7.
   PubMed Web of Science ®Google Scholar
• Li Y, Tollefsbol TO. DNA methylation detection: bisulfite genomic sequencing analysis. Methods Mol Biol 2011;791:11–21.
   PubMedGoogle Scholar
• Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol 2011;7:219–31.
   PubMed Web of Science ®Google Scholar
• Abbott DH, Dumesic DA, Franks S. Developmental origin of polycystic ovary syndrome – a hypothesis. J Endocrinol 2002;174:1–5.
   PubMed Web of Science ®Google Scholar
• Dumesic DA, Abbott DH, Padmanabhan V. Polycystic ovary syndrome and its developmental origins. Rev Endocr Metab Disord 2007;8:127–41.
   PubMed Web of Science ®Google Scholar
• Franks S, Berga SL. Does PCOS have developmental origins? Fertil Steril 2012;97:2–6.
   PubMed Web of Science ®Google Scholar
• Gur EB, Karadeniz M, Turan GA. Fetal programming of polycystic ovary syndrome. World J Diabetes 2015;6:936–42.
   PubMed Web of Science ®Google Scholar
• Abbott DH, Tarantal AF, Dumesic DA. Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys. Am J Primatol 2009;71:776–84.
   PubMed Web of Science ®Google Scholar
• Xu N, Kwon S, Abbott DH, et al. Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes in prenatally androgenized rhesus monkeys. PLoS One 2011;6:e27286.
   PubMed Web of Science ®Google Scholar
• Hogg K, McNeilly AS, Duncan WC. Prenatal androgen exposure leads to alterations in gene and protein expression in the ovine fetal ovary. Endocrinology 2011;152:2048–59.
   PubMed Web of Science ®Google Scholar
• Connolly F, Rae MT, Späth K, et al. In an ovine model of polycystic ovary syndrome (PCOS) prenatal androgens suppress female fetal renal gluconeogenesis. PLoS One 2015;10:e0132113.
   Web of Science ®Google Scholar
• Wang F, Yu B, Yang W, et al. Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats. J Ovarian Res 2012;5:15.
   PubMed Web of Science ®Google Scholar
• Nilsson E, Larsen G, Manikkam M, et al. Environmentally induced epigenetic transgenerational inheritance of ovarian disease. PLoS One 2012;7:e36129.
   PubMed Web of Science ®Google Scholar
• Hague WM, Adams J, Rodda C, et al. The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives. Clin Endocrinol (Oxf) 1990;33:501–10.
   PubMed Web of Science ®Google Scholar
• Morishima A, Grumbach MM, Simpson ER, et al. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995;80:3689–98.
   PubMed Web of Science ®Google Scholar
• Qu F, Wang FF, Yin R, et al. A molecular mechanism underlying ovarian dysfunction of polycystic ovary syndrome: hyperandrogenism induces epigenetic alterations in the granulosa cells. J Mol Med (Berl) 2012;90:911–23.
   PubMed Web of Science ®Google Scholar
• Li Z, Huang H. Epigenetic abnormality: a possible mechanism underlying the fetal origin of polycystic ovary syndrome. Med Hypotheses 2008;70:638–42.
   PubMed Web of Science ®Google Scholar
• Xu N, Azziz R, Goodarzi MO. Epigenetics in polycystic ovary syndrome: a pilot study of global DNA methylation. Fertil Steril 2010;94:781–3.
   PubMed Web of Science ®Google Scholar
• Shen HR, Qiu LH, Zhang ZQ, et al. Genome-wide methylated DNA immunoprecipitation analysis of patients with polycystic ovary syndrome. PLoS One 2013;8:e64801.
   PubMed Web of Science ®Google Scholar
• Wang XX, Wei JZ, Jiao J, et al. Genome-wide DNA methylation and gene expression patterns provide insight into polycystic ovary syndrome development. Oncotarget 2014;5:6603–10.
   PubMed Web of Science ®Google Scholar
• Yu YY, Sun CX, Liu YK, et al. Genome-wide screen of ovary-specific DNA methylation in polycystic ovary syndrome. Fertil Steril 2015;104:145–53.
   PubMed Web of Science ®Google Scholar
• Li S, Zhu D, Duan H, et al. Differential DNA methylation patterns of polycystic ovarian syndrome in whole blood of Chinese women. Oncotarget 2016. [Epub ahead of print]. doi: 10.18632/oncotarget.9327.
   Google Scholar
• Kokosar M, Benrick A, Perfilyev A, et al. Epigenetic and transcriptional alterations in human adipose tissue of polycystic ovary syndrome. Sci Rep 2016;6:22883.
   PubMed Web of Science ®Google Scholar
• Xu J, Bao X, Peng Z, et al. Comprehensive analysis of genome-wide DNA methylation across human polycystic ovary syndrome ovary granulosa cell. Oncotarget 2016;7:27899–909.
   PubMed Web of Science ®Google Scholar
• Ma B, Wilker EH, Willis-Owen SA, et al. Predicting DNA methylation level across human tissues. Nucleic Acids Res 2014;42:3515–28.
   PubMed Web of Science ®Google Scholar
• Tsai PC, Spector TD, Bell JT. Using epigenome-wide association scans of DNA methylation in age-related complex human traits. Epigenomics 2012;4:511–26.
   PubMed Web of Science ®Google Scholar
• Glintborg D, Hass Rubin K, Nybo M, et al. Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome. Eur J Endocrinol 2015;172:627–38.
   PubMed Web of Science ®Google Scholar
• Janssen OE, Mehlmauer N, Hahn S, et al. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol 2004;150:363–9.
   PubMed Web of Science ®Google Scholar
• Du D, Li X. The relationship between thyroiditis and polycystic ovary syndrome: a meta-analysis. Int J Clin Exp Med 2013;6:880–9.
   PubMed Web of Science ®Google Scholar
• Gaberšček S, Zaletel K, Schwetz V, et al. Mechanisms in endocrinology: thyroid and polycystic ovary syndrome. Eur J Endocrinol 2015;172:R9–21.
   PubMed Web of Science ®Google Scholar
• Ali AFM, Fateen B, Ezzet A, et al. Polycystic ovary syndrome as an autoimmune disease: a new concept. Obstet Gynecol 2000;95:S48.
   PubMed Web of Science ®Google Scholar
• Petríková J, Lazúrová I, Yehuda S. Polycystic ovary syndrome and autoimmunity. Eur J Intern Med 2010;21:369–71.
   PubMed Web of Science ®Google Scholar
• Conway GS, Honour JW, Jacobs HS. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol 1989;30:459–70.
   PubMed Web of Science ®Google Scholar
• Zhang HY, Guo CX, Zhu FF, et al. Clinical characteristics, metabolic features, and phenotype of Chinese women with polycystic ovary syndrome: a large-scale case-control study. Arch Gynecol Obstet 2013;287:525–31.
   PubMed Web of Science ®Google Scholar
• Jones MR, Brower MA, Xu N, et al. Systems genetics reveals the functional context of PCOS loci and identifies genetic and molecular mechanisms of disease heterogeneity. PLoS Genet 2015;11:e1005455.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF, Samino S, Insenser M, et al. Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS. Clin Chem 2012;58:999–1009.
   PubMed Web of Science ®Google Scholar